Hosted on MSN
Core Laboratories outlines Q3 2025 revenue guidance of $127.5M-$134.5M amid margin improvements and global expansion
CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...
Shares of Core Laboratories Inc. CLB gained momentum over the last month, following a staggering rise of 13% in just one month. During the same time period, the company’s shares outperformed the ...
due to a change in probability of performance conditions for certain executives' share awards. The year ended December 31, 2024 includes reversals of stock compensation expense previously recognized ...
probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results